Javascript must be enabled to continue!
B1a cells protect againstSchistosoma japonicum–induced liver inflammation and fibrosis by controlling monocyte infiltration
View through CrossRef
AbstractDuringSchistosomainfection, lack of B cells results in more severe granulomas, inflammation, and fibrosis in the liver, but the mechanisms underlying this pathology remain unclear. Thus, our aim was to clarify the mechanisms underpinning the immunomodulation of B cells in mice infected withSchistosoma japonicum. We found that B cell deficiency led to aggravated liver pathology, as demonstrated by increases in the size of the egg-associated granulomas, alanine transaminase levels, and collagen deposition. Compared with infected wild-type mice, infected B cell–deficient μMT mice showed increased infiltration of Ly6Chimonocytes and higher levels of proinflammatory cytokines (tumor necrosis factor alpha, interleukin 6, and interleukin 12) and chemokines ([C-C motif] ligands (CCL)2, CCL3, CCL4, and CCL5). The results of flow cytometric analysis and cell transfer experiments showed that B1a cells increased significantly in the liver followingS. japonicuminfection, with some of those cells deriving from the peritoneal cavity. We also found that secretion of IL-10 from hepatic B cells increased significantly in infected wild-type mice and that this IL-10 was mainly derived from B1a cells. In addition, adoptively transferring peritoneal cavity B cells purified from wild-type, but not from IL-10–deficient mice, to μMT mice significantly reduced liver pathology and liver infiltration of Ly6Chimonocytes. These reductions were accompanied by decreases in the expression levels of chemokines and inflammatory cytokines. Taken together, these data indicated that afterS. japonicuminfection, an increased number of hepatic B1a cells secrete IL-10, which inhibits the expression of chemokines and cytokines and suppresses the infiltration of Ly6Chimonocytes into the liver thereby alleviating liver early inflammation and late fibrosis. Understanding this immunomodulatory role of B1a cells in schistosomiasis may lead to the development of therapeutic strategies forSchistosoma-induced liver disease.Author summaryInfection withSchistosoma,a waterborne parasitic flatworm (trematode) commonly called a blood fluke, results in strong granulomatous inflammation caused by the deposition of eggs in the liver. A granuloma is a substantial immune cell infiltration around the eggs intermixed with liver cells that can protect the host against liver damage. However, excessive infiltration and inflammation can lead to severe liver injury and fibrosis. Here, we found that B1a cells accumulate in the liver of mice afterS. japonicum–induced infection and that these B1a cells release the anti-inflammatory cytokine interleukin 10 to regulate inflammation. The B1a cell–derived interleukin 10 inhibits the expression of chemokines (which attract cells such as monocytes to sites of infection or inflammation) and thus restrains excessive infiltration of Ly6Chimonocytes (which may have proinflammatory activity) into the liver, thereby alleviating early inflammation and later fibrosis. Our study provides insight into the immunomodulation of B1a cells in schistosomiasis and offers key information for the development of therapeutic strategies inSchistosoma-induced liver disease.
Title: B1a cells protect againstSchistosoma japonicum–induced liver inflammation and fibrosis by controlling monocyte infiltration
Description:
AbstractDuringSchistosomainfection, lack of B cells results in more severe granulomas, inflammation, and fibrosis in the liver, but the mechanisms underlying this pathology remain unclear.
Thus, our aim was to clarify the mechanisms underpinning the immunomodulation of B cells in mice infected withSchistosoma japonicum.
We found that B cell deficiency led to aggravated liver pathology, as demonstrated by increases in the size of the egg-associated granulomas, alanine transaminase levels, and collagen deposition.
Compared with infected wild-type mice, infected B cell–deficient μMT mice showed increased infiltration of Ly6Chimonocytes and higher levels of proinflammatory cytokines (tumor necrosis factor alpha, interleukin 6, and interleukin 12) and chemokines ([C-C motif] ligands (CCL)2, CCL3, CCL4, and CCL5).
The results of flow cytometric analysis and cell transfer experiments showed that B1a cells increased significantly in the liver followingS.
japonicuminfection, with some of those cells deriving from the peritoneal cavity.
We also found that secretion of IL-10 from hepatic B cells increased significantly in infected wild-type mice and that this IL-10 was mainly derived from B1a cells.
In addition, adoptively transferring peritoneal cavity B cells purified from wild-type, but not from IL-10–deficient mice, to μMT mice significantly reduced liver pathology and liver infiltration of Ly6Chimonocytes.
These reductions were accompanied by decreases in the expression levels of chemokines and inflammatory cytokines.
Taken together, these data indicated that afterS.
japonicuminfection, an increased number of hepatic B1a cells secrete IL-10, which inhibits the expression of chemokines and cytokines and suppresses the infiltration of Ly6Chimonocytes into the liver thereby alleviating liver early inflammation and late fibrosis.
Understanding this immunomodulatory role of B1a cells in schistosomiasis may lead to the development of therapeutic strategies forSchistosoma-induced liver disease.
Author summaryInfection withSchistosoma,a waterborne parasitic flatworm (trematode) commonly called a blood fluke, results in strong granulomatous inflammation caused by the deposition of eggs in the liver.
A granuloma is a substantial immune cell infiltration around the eggs intermixed with liver cells that can protect the host against liver damage.
However, excessive infiltration and inflammation can lead to severe liver injury and fibrosis.
Here, we found that B1a cells accumulate in the liver of mice afterS.
japonicum–induced infection and that these B1a cells release the anti-inflammatory cytokine interleukin 10 to regulate inflammation.
The B1a cell–derived interleukin 10 inhibits the expression of chemokines (which attract cells such as monocytes to sites of infection or inflammation) and thus restrains excessive infiltration of Ly6Chimonocytes (which may have proinflammatory activity) into the liver, thereby alleviating early inflammation and later fibrosis.
Our study provides insight into the immunomodulation of B1a cells in schistosomiasis and offers key information for the development of therapeutic strategies inSchistosoma-induced liver disease.
Related Results
Initial study of biexponential model of intravoxel incoherent motion magnetic resonance imaging in evaluation of the liver fibrosis
Initial study of biexponential model of intravoxel incoherent motion magnetic resonance imaging in evaluation of the liver fibrosis
Background
The diagnosis of liver fibrosis is a difficult task at any time using conventional clinical imaging. Intravoxel incoherent motion (IVIM) can be used to inves...
Hepatic BRD4 Is Upregulated in Liver Fibrosis of Various Etiologies and Positively Correlated to Fibrotic Severity
Hepatic BRD4 Is Upregulated in Liver Fibrosis of Various Etiologies and Positively Correlated to Fibrotic Severity
Bromodomain-containing protein 4 (BRD4) has been implicated to play a regulatory role in fibrogenic gene expression in animal models of liver fibrosis. The potential role of BRD4 i...
Characteristics of Peripheral Lymphocyte Subsets in Patients with Different Stages of Schistosomiasis Japonica
Characteristics of Peripheral Lymphocyte Subsets in Patients with Different Stages of Schistosomiasis Japonica
Background Immune cells are important for the development of
schistosomiasis japonica and are also critical for the treatment of
schistosomiasis. The immune cells in the peripheral...
25(OH) D3 alleviate liver NK cytotoxicity in acute but not in chronic fibrosis model of BALB/c mice due to modulations in vitamin D receptor
25(OH) D3 alleviate liver NK cytotoxicity in acute but not in chronic fibrosis model of BALB/c mice due to modulations in vitamin D receptor
Abstract
Background
Low 25-Hydroxy-vitamin-D; “25(OH)-D3” serum and vitamin D receptor (VDR) levels were recently correlated to advanced fibrosis. However, VDR mechanism in liver f...
Neutrophils alleviate fibrosis in the CCl4‐induced mouse chronic liver injury model
Neutrophils alleviate fibrosis in the CCl4‐induced mouse chronic liver injury model
Tribbles pseudokinase 1 (Trib1) is a negative regulator of CCAAT/enhancer binding protein α (C/EBPα) and is known to induce granulopoiesis while suppressing monocyte differentiatio...
THE PERFORMANCE OF GPRI, FIB-4 AND LIVER ELASTOGRAPHY FOR DIAGNOSING LIVER FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS B
THE PERFORMANCE OF GPRI, FIB-4 AND LIVER ELASTOGRAPHY FOR DIAGNOSING LIVER FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS B
After assessing liver fibrosis stages of 83 patients with chronic hepatitis B using GPRI, FIB-4 and ElastPQ, we have the following conclusions:
GPRI had a good accuracy for d...
COMPARATIVE ACCURACY OF 2-D SHARE WAVE ELASTOGRAPHY WITH CHILD PUGH SCORING IN LIVER FIBROSIS
COMPARATIVE ACCURACY OF 2-D SHARE WAVE ELASTOGRAPHY WITH CHILD PUGH SCORING IN LIVER FIBROSIS
Background: Liver fibrosis is a progressive response to chronic liver injury, resulting in scar tissue formation and potential evolution into cirrhosis. Early and accurate staging ...
Abstract 5638: Liver preclinical models - acute, chronic and cancer models
Abstract 5638: Liver preclinical models - acute, chronic and cancer models
Abstract
Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related death and accounts for >80% of primary liver cancer worldwide. Early sta...


